AN1 Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for AN1 (AN1) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| ATX Amplia Therapeutics Limited | $0.17 +3.12% |
| CTE Cryosite Limited | $1.09 +0.00% |
| ASP Aspermont Limited | $1.98 +7.63% |
| BXN Bioxyne Limited | $0.07 +2.99% |
| ATH Alterity Therapeutics Limited | $0.01 +25.00% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| ATX Amplia Therapeutics Limited | $0.17 | +3.12% | 84.66 M | -8.25 | -0.02 | 0.00% | Buy | 2.04 |
| CTE Cryosite Limited | $1.09 | +0.00% | 53.20 M | 27.25 | 0.04 | 0.00% | Hold | 1 |
| ASP Aspermont Limited | $1.98 | +7.63% | 23.00 M | -5.64 | -0.35 | 0.00% | Buy | 1 |
| BXN Bioxyne Limited | $0.07 | +2.99% | 156.58 M | -6.90 | -0.01 | 0.00% | — | 1.89 |
| ATH Alterity Therapeutics Limited | $0.01 | +25.00% | 108.75 M | -1.00 | -0.01 | 0.00% | Buy | 5.14 |
Frequently Asked Questions
What are AN1's latest financial results?
Review AN1's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has AN1's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is AN1's cash flow situation and liquidity?
Cash flow statements reveal how AN1 generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does AN1's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether AN1 is outperforming or lagging within its sector.
Are AN1's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether AN1's profits are repeatable and supported by strong fundamentals.